The RUNX1 Research Program awards grants through two annual programs with its partners Alex's Lemonade Stand Foundation and the Leukemia and Lymphoma Society.
Our second grant cycle is now open. Letters of Intent are due by June 1, 2017.
Alex's Lemonade Stand Foundation Program
The Babich Family Foundation is dedicated to advancing areas of research of particular importance to families affected by FPD/AML due to germline RUNX1 mutations with the ultimate goal of developing effective therapies to prevent the onset of AML. Alex's Lemonade Stand Foundation (ALSF) is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers.
Awards are for $125,000 per year for two years for research leading to the prevention of the transition from pre-leukemia to leukemia for patients with the familial RUNX1 disorder. 2016 grants were recently awarded.
Our second grant cycle is now open.
The Leukemia and Lymphoma Society Program
The Babich Family Foundation has partnered with The Leukemia and Lymphoma Society (LLS) to provide grants of $200,000 per year for three years for translational leukemia research related to the germline RUNX1 disorder. Applicants are expected to submit preliminary data in support of their grant and have specific aims towards clinical applications.
The Babich Family Foundation/LLS Grant Program for 2018 will be announced in September 2017 as part of the LLS TRP announcements.